Elev8 Brands, Inc. Signs New Manufacturing Agreement with Canbiola, Inc.

Elev8 Brands, Inc. Expands Product Line


ORLANDO, FL -- October 22, 2018 -- InvestorsHub NewsWire -- Elev8 Brands, Inc. (OTCQB: VATE), a holding company focused on the commercial development of hemp and CBD-based products including hemp coffee, hemp tea, hemp Cold Brew, CBD salve, CBD Lotions and CBD Tinctures that target the health and wellness markets, is pleased to announce it has signed a manufacturing and supply agreement with Canbiola, Inc. (OTC Pink: CANB) the Master Distributor for Pure Health Products, LLC for the manufacturing of its new Zoe CBD CryoGel.


This all new CryoGel is an all-natural gel that not only helps to relieve pain, but is also Vegan, Non-GMO, Non-GE, and made with all-natural and organic components. This product is a fast-acting all-natural CBD CryoGel infuses 99.9% pure CBD.
Elev8 Brands, Inc.’s CEO, Ryan Medico, stated, “I have had some great conversations with Canbiola CEO, Marco Alfonsi. We share in the same passions and look forward to developing a deeper working relationship.”


Marco Alfonsi, CEO of Canbiola, said, “Canbiola is a company that is passionate about improving people’s lives through bringing the highest quality lab tested products to market with all-natural ingredients. With Elev8 Brands, Inc. and Canbiola having many synergies, it makes sense to work together for the expansion of our products and respective brands.”
Medico concluded, “This is a very exciting time in the world of hemp and CBD. Finding opportunities to grow and work together is key. Canbiola is a Company that we can expand our product line with knowing they provide some of the highest quality CBD around.”

About Elev8 Brands, Inc.:

Elev8 Brands, Inc. specializes in the development and marketing of products for the fitness and wellness markets. The company is founded based on creating high-quality, sustainable, products for health- conscious consumers.

About Elev8 Hemp LLC:

Elev8 Hemp LLC is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of hemp-based food, beverage, and health care products including hemp coffee and hemp tea.

About 02 Breathe LLC:

02 Breathe is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on their oxygen bar while bringing in an array of CBD products. O2 Breathe carries CBD tinctures, CBD vape, CBD lotions and massage products. 02 Breathe is currently looking to offer CBD at their oxygen bar.

About Zoe CBD LLC:

Zoe CBD is a wholly-owned subsidiary of Elev8 Brands, Inc. which focuses on the development and marketing of CBD-based products such as CBD Tinctures, CBD E-Juice, CBD Lotion and CBD Salve. Please visit, http://www.zoecbd.com for more information

www.facebook.com/elev8hemp www.instagram.com/elev8hemp www.twitter.com/elev8hemp www.02breathe.com
www.elev8hemp.com


About Canbiola, Inc.
Canbiola, Inc. is a public company trading under symbol CANB.
Canbiola, Inc. is a US Company embarking in the sale of a variety of Cannabidiol (CBD) based products. Canbiola is in the process of developing its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states. The company has already launched several products found at www.canbiola.com.  Follow us on Twitter and Facebook


Safe Harbor Statement:
The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimate," "project," "intend," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technological advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, and various other factors beyond the Company's control.